Supplementary Materials and Methods
Tissue specimens and primary cell isolation. The current study was conducted on 119 LAD specimens, which were histopathologically and clinically diagnosed at the Cancer Center of Sun Yat-sen University (SYSUCC) from 2001 to 2008. These specimens are defined as the SYSUCC cohort. Clinical information regarding the research subjects is summarized in SI Appendix, Table S2 . LAD and paired adjacent noncancerous lung specimens were stored frozen in liquid nitrogen until further use.
Adjacent non-tumor specimens were obtained from a standard distance (3 cm) from the tumor margin in resected tissues of patients with LAD who underwent surgical lung resection and confirmed by pathological diagnosis. Prior patient consents and approval from the Institutional Research Ethics Committee of Sun Yat-sen University were obtained for the use of these clinical materials for research purposes.
The preparation of LAD cells from resected samples was conducted as described previously (1). Briefly, LAD cells freshly isolated from patients were rinsed twice with PBS supplemented with penicillin/streptomycin (Gibco, Grand Island, NY) and minced with scissors. Tumor fragments were immediately put into ACL4 medium supplemented with 5% fetal bovine serum and penicillin/streptomycin. After the removal of blood clots, the tissue pieces were collected and washed with PBS containing penicillin/streptomycin, followed by suspending the cells in ACL4 medium containing 5% fetal bovine serum and penicillin/streptomycin and incubated in collagen-coated flasks.
Plasmids. Full-length LINC00673-v4 was cloned into pSin-EF2-puro retroviral vector (Addgene, Cambridge, MA). For expressing short hairpin RNA (shRNA), oligonucleotides (target sequences see SI Appendix, Table S12) were annealed and then plasmids were transfected into the PT67, an NIH3T3-derived packaging cell line (Clontech, Mountain View, CA), using Lipofectamine 3000 reagent (Invitrogen, San Diego, CA). Subsequently, the supernatants were collected and incubated with cells to be infected for 24 h in the presence of polybrene (8 μg/ml). After infection, puromycin (1 μg/ml) was used for 10 days to select stably transduced cells.
Western blotting (WB) analysis. WB analysis was performed according to a previously described standard method (3) using antibodies anti-CK1ε and anti-DDX3 
RNA extraction and quantitative reverse transcription-PCR (qRT-PCR). Total
RNA was isolated from cultured cells or surgically resected fresh LAD tissues using TRIzol (Invitrogen) according to the manufacturer's instructions. Total RNA of the formalin-fixed paraffin-embedded (FFPE) tissue sections was isolated using the RecoverAll TM Total Nucleic Acid Isolation Kit for FFPE according to the supplier's instruction. The first-strand cDNA was generated by RT using MMLV transcriptase (Promega, Madison, WI) and random primers. Real-time qRT-PCR was performed on a CFX96 real-time PCR detection system (Bio-Rad, Richmond, CA). The sequences of the primers are listed in SI Appendix, Table S14 .
Cell nucleus/cytoplasm fraction isolation. Cell nucleus/cytoplasm fraction isolation was performed using Nuclear and Cytoplasmic Extraction Kit (Thermo, Waltham, MA) according to the supplier's recommendation. Germany).
RNA fluorescence in situ hybridization (FISH

In situ Proximity ligation assays (PLA). Interactions between DDX3 and CK1were
detected by in situ PLA. The assay was performed using Duolink ® PLA Kit (Sigma) according to the supplier's instruction.
Wound healing, cell invasion, and migration assays. For wound healing assay, confluent cells in 6-well plates were pretreated with 10 µg/ml mitomycin C (Sigma) for 2 h to inhibit cell mitosis and then scratched with a pipette tip. Table S15 ) at 55°C overnight. After incubation for 1 h at room temperature with anti-digoxin monoclonal antibody (Roche), the sections were stained with Nuclear Fast Red (2-anthracenesulfonic acid, 4-amino-9, 10-dihydro-1, 3-dihydroxy-9, 10-dioxo-, monosodium salt), mounted and examined. IHC assays were performed and quantified as previously described (5) The staining intensity was recorded on a scale of 0 (no staining), 1 (week staining), 2
(moderate staining), and 3 (strong staining). The staining index (SI) was calculated as follows: SI=staining intensity × proportion of positively stained cells, resulting in scores of 0, 1, 2, 3, 4, 6, or 9. The selection of cutoff scores were based on receiver operating characteristic (ROC) curve analysis. ROC curve was generated by plotting the sensitivity and specificity of each score. The score located closest to the point with both maximum sensitivity and specificity was determined as the cutoff score (6, 7).
Northern blotting analysis. Total RNA was isolated from LAD cells and ribosomal RNA was depleted using Ribo-off rRNA Depletion Kit (Vazyme, Jiangsu, China)
according to the manufacturer's instructions. Then the isolated RNA was dissolved in 2×
RNA loading buffer (95% formamide, 0.025% lauryl sodium sulfate, 0.025% bromophenol blue, 0.025% xylene cyanol, 0.025% ethidium bromide and 0.5 mM edetic acid). Samples were loaded onto 15% denaturing TBE-urea gels and then transferred onto positively charged nylon membranes (Roche, Basel, Switzerland). The blotted membranes were prehybridized at 65°C for 1 h using hybridization buffer (Roche) and subjected to hybridization with digoxin-labelled DNA probe (50 μM) targeted against LINC00673 (Exiqon, Vedbaek, Danmark) overnight at room temperature. Probe (for sequence, see SI Appendix, Table S15 ) detection was performed using a digoxin Luminescent Detection Kit (Roche) according to the manufacturer's protocol. After the blots were equilibrated in detection buffer, they were incubated with the chemiluminescent substrate CDP-Star and used to expose Kodak Biomax MR film.
Co-immunoprecipitation (Co-IP). Indicated cells were washed in PBS and lysed with
cell lysis buffer (25 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 2% Glycerol, 0.2% Cocktail, pH 7.4) supplemented with RNase inhibitor (Promega), and the lysates were then captured by 50 μl of anti-Flag magnetic beads or anti-mouse immunoglobulin G (IgG) agarose beads (Sigma). After 24 h, the magnetic beads were washed six times with wash buffer (20 mM HEPES, 300 mM NaCl, 1 mM EDTA, 0.1% NP-40, and 0.1% Glycerol, pH 7.4). Both the input and co-IP samples were analyzed by WB analysis using anti-Flag or anti-CK1ε antibodies as described above.
RNA immunoprecipitation (RIP)
. RIP was performed using Magna RIP RNABinding Protein Immunoprecipitation Kit (Millipore, Billerica, MA) according to the manufacturer's instructions with additional UV crosslink step as described previously (8).
Briefly, indicated cells in 10 ml ice-cold PBS were UV-crosslinked with 100,000 μJ/cm Reporter activity detected was normalized by Renilla luciferase activity (each bar represents the mean ± SD derived from three independent experiments, two-tailed Student's t test. *P < 0.05, ***P < 0.001). experiments, one-way ANOVA followed by Dunnett's multiple comparison test. *P < 0.05, **P < 0.01, ***P < 0.001).
Fig. S5. LINC00673-v4 regulates LAD cell invasion and migration in vitro.
(A) PC9, HCC827 and NCI-H2030 cell lines stably transduced with ectopic LINC00673-v4 or knocked down for LINC00673-v4 were constructed (left: each bar represents the mean ± SD derived from three independent experiments, two-tailed Student's t test; right:
each bar represents the mean ± SD derived from three experiments, one-way ANOVA followed by Dunnett's multiple comparison test. *P < 0.05, **P < 0.01, ***P < 0.001). two-tailed Student's t test. *P < 0.05, **P < 0.01, ***P < 0.001).
Fig. S8. Subcellular β-catenin localization in indicated cells.
Subcellular β-catenin localization was assessed using immunofluorescence staining and representative images are shown. Specific bands were identified by mass spectrum. In situ Proximity Ligation Assay was performed to assess the interaction between DDX3
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